Revolution Medicines Total Non-Operating Income/Expense 2018-2024 | RVMD
Revolution Medicines total non-operating income/expense for the twelve months ending June 30, 2024 was $0.078B, a 205.38% increase year-over-year.
- Revolution Medicines annual total non-operating income/expense for 2023 was $0.047B, a 416.65% increase from 2022.
- Revolution Medicines annual total non-operating income/expense for 2022 was $0.009B, a 898.26% increase from 2021.
- Revolution Medicines annual total non-operating income/expense for 2021 was $0.001B, a 57.68% decline from 2020.